Annual Total Long Term Liabilities
$45.17 M
+$277.00 K+0.62%
31 December 2023
Summary:
Cytek Biosciences annual total long term liabilities is currently $45.17 million, with the most recent change of +$277.00 thousand (+0.62%) on 31 December 2023. During the last 3 years, it has fallen by -$164.30 million (-78.44%). CTKB annual total long term liabilities is now -78.44% below its all-time high of $209.47 million, reached on 31 December 2020.CTKB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$42.97 M
+$743.00 K+1.76%
30 September 2024
Summary:
Cytek Biosciences quarterly total long term liabilities is currently $42.97 million, with the most recent change of +$743.00 thousand (+1.76%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-4.97%). CTKB quarterly long term liabilities is now -79.84% below its all-time high of $213.10 million, reached on 30 June 2021.CTKB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.6% | -5.0% |
| 3 y3 years | -78.4% | +103.5% |
| 5 y5 years | - | - |
CTKB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.4% | +82.6% | -9.1% | +103.5% |
| 5 y | 5 years | -78.4% | +82.6% | -79.8% | +103.5% |
| alltime | all time | -78.4% | +82.6% | -79.8% | +103.5% |
Cytek Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.97 M(+1.8%) |
| June 2024 | - | $42.22 M(-3.8%) |
| Mar 2024 | - | $43.89 M(-2.8%) |
| Dec 2023 | $45.17 M(+0.6%) | $45.17 M(-0.1%) |
| Sept 2023 | - | $45.21 M(-4.4%) |
| June 2023 | - | $47.28 M(+6.0%) |
| Mar 2023 | - | $44.60 M(-0.7%) |
| Dec 2022 | $44.89 M | $44.89 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $41.29 M(+5.0%) |
| June 2022 | - | $39.34 M(+10.4%) |
| Mar 2022 | - | $35.63 M(+44.0%) |
| Dec 2021 | $24.74 M(-88.2%) | $24.74 M(+17.2%) |
| Sept 2021 | - | $21.11 M(-90.1%) |
| June 2021 | - | $213.10 M(+0.9%) |
| Mar 2021 | - | $211.26 M(+0.9%) |
| Dec 2020 | $209.47 M(+130.1%) | $209.47 M |
| Dec 2019 | $91.02 M | - |
FAQ
- What is Cytek Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cytek Biosciences?
- What is Cytek Biosciences annual total long term liabilities year-on-year change?
- What is Cytek Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cytek Biosciences?
- What is Cytek Biosciences quarterly long term liabilities year-on-year change?
What is Cytek Biosciences annual total long term liabilities?
The current annual total long term liabilities of CTKB is $45.17 M
What is the all time high annual total long term liabilities for Cytek Biosciences?
Cytek Biosciences all-time high annual total long term liabilities is $209.47 M
What is Cytek Biosciences annual total long term liabilities year-on-year change?
Over the past year, CTKB annual total long term liabilities has changed by +$277.00 K (+0.62%)
What is Cytek Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of CTKB is $42.97 M
What is the all time high quarterly long term liabilities for Cytek Biosciences?
Cytek Biosciences all-time high quarterly total long term liabilities is $213.10 M
What is Cytek Biosciences quarterly long term liabilities year-on-year change?
Over the past year, CTKB quarterly total long term liabilities has changed by -$2.25 M (-4.97%)